NASDAQ: BRTX
Biorestorative Therapies Inc Earnings Dates, Reports, Calls

Biorestorative Therapies earnings were -$12.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest BRTX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$5.3M, up 226.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BRTX reported annual earnings of -$9.0M, with -13.8% growth.

BRTX earnings history

Current Revenue
$391.0k
Current Earnings
-$12.1M
Current Profit Margin
-3,093.6%

BRTX Return on Equity

Current Company
-136.4%
Current Industry
-60.5%
Current Market
28.6%
BRTX's Return on Equity (-136.4%)... subscribe to Premium to read more.
High Return on Equity Performance

BRTX undefined

Current Company
-90.8%
Current Industry
-2%
BRTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BRTX announces earnings.

BRTX undefined

Current Company
-196.85%
Current Industry
6.4%
BRTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BRTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BRTX-$11.78M-$12.10MN/A-$1.47
NXTC-$46.24M-$49.52MN/A-$1.76
ASBP-$17.14M-$17.53MN/A-$0.16
INAB-$24.73M-$27.43MN/A-$0.45
MRKR-$12.73M-$12.78MN/A-$1.33

Biorestorative Therapies Earnings Reports & History FAQ

What were Biorestorative Therapies's earnings last quarter?

On BRTX's earnings call on Invalid Date, Biorestorative Therapies (NASDAQ: BRTX) reported Q1 2025 earnings per share (EPS) of -$0.64, up 93.94% year over year. Total BRTX earnings for the quarter were -$5.34 million. In the same quarter last year, Biorestorative Therapies's earnings per share (EPS) was -$0.33.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.

Is Biorestorative Therapies profitable or losing money?

As of the last Biorestorative Therapies earnings report, Biorestorative Therapies is currently losing money. Biorestorative Therapies's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$12.10 million, a 121.2% increase year over year.

What was BRTX's earnings growth in the past year?

As of Biorestorative Therapies's earnings date in Invalid Date, Biorestorative Therapies's earnings has grown year over year. BRTX earnings in the past year totalled -$12.10 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.